Riskpilot← Back to searchSign inGet full accessRETROGENE AS
ASActiveOrg 913047923Edvard Griegs Vei 3A, 5059 BergenPublishing of video games · NACE 5821Est. 20140 employeeswww.retrogenestudio.com
Revenue 2024
NOK 0
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2024
NOK -3K
0 employees
| Revenue | NOK 0 | — |
| EBITDA | NOK -3K | — |
| Net profit | NOK -3K | — |
| Total assets | NOK 12K | -19% |
| Equity | NOK 12K | -19% |
| Employees | 0 | — |
Legal name
RETROGENE AS
Org number
913047923
Legal form
Aksjeselskap
NACE code
5821 · Publishing of video games
Founded
9. januar 2014
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Produsere interaktiv underholdning av høy kvalitet, solgt via digitale distribusjonskanaler. Selskapet vil også tilby å selge tjenester som faller innunder dets kompetanse.
Address
Edvard Griegs Vei 3A, 5059 Bergen
Website
www.retrogenestudio.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 7 | 6 | 0 | 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −58 | −126 | −140 | −36 | 10 | −3 | −0 | −1 | 0 | 0 | −3 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −58 | −126 | −140 | −36 | 10 | −3 | −0 | −1 | 0 | 0 | −3 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −0 | 0 | 0 | 0 |
| Profit before tax | −58 | −126 | −140 | −36 | 10 | −3 | −0 | −1 | 0 | 0 | −3 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| Net profit | −58 | −126 | −140 | −36 | 10 | −3 | −0 | −1 | 0 | 0 | −3 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 20 | 19 | 10 | 9 | 19 | 16 | 16 | 15 | 15 | 15 | 12 |
| Equity | 20 | 19 | 10 | 9 | 19 | 16 | 16 | 15 | 15 | 15 | 12 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITDA margin
-283300.0%
This company
15.8%
Market median
-1793138% vs market
20142024
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20142024
Return on equity
-23.6%
This company
18.4%
Market median
-228% vs market
20142024
Net profit margin
-283300.0%
This company
8.1%
Market median
-3497631% vs market
20142024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20142024
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2022 | |
| Individual | 16.7% | 16.7% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RETROGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|